en

PRODUCT DETAIL

Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan 600 mg/200 mg/245 mg filmom obalené tablety

Code 6270C
MA number EU/1/17/1222/002
Product Form: tbl flm 90 (3x30)x600 mg/200 mg/245 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 05.09.2017
Validity: 05.09.2022
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 05.09.2019
eu-flag.png sk-flag.png